Altre lingue Azitra, Inc.

Azioni

AZTR

US05479L2034

Tempo reale stimato Cboe BZX Altri mercati azionari 16:26:36 03/07/2024			Variaz. 5gg	Var. 1 gen.
2,25 ^USD	+3,21%		-38,73%	-92,20%

10/05	Azitra, Inc. annuncia i dati preclinici positivi di ATR-12 e il progetto clinico nella sindrome di Netherton, presentato al meeting annuale dell'ASGCT.	CI
09/05	Azitra, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Azitra, Inc. Announces Reverse Stock Split	27/06
Certain Options of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024.	16/06
Certain Warrants of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024.	16/06
Certain Common Stock of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024.	16/06
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention	03/06
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention	31/05
Azitra Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting	20/05
Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting	17/05
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	13/05
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	10/05
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	10/05
Azitra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates	09/05
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting	22/04
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting	22/04
Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024	18/04
Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates	15/03
Azitra, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Azitra Closes $5 Million Public Offering	16/02
Azitra, Inc. Announces Closing of Public Offering	16/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Azitra, Inc.

Azioni

AZTR

US05479L2034

Altre lingue

Filtri